Sapu Bioscience today announced advancements in its global IP portfolio supporting OT-101, its proprietary TGF-β antisense ...

Investing.com -- Coherus BioSciences Inc (NASDAQ:CHRS) stock tumbled 14.5% in premarket trading on Friday after the oncology company announced the pricing of a public offering of 28.6 million shares ...

Solid Biosciences Inc. is a Strong Buy driven by positive FDA alignment on phase 3 IMPACT DUCHENNE trial for SGT-003. Read ...

BEAVERTON, OR, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Sedia Biosciences Corporation, a leading developer ...

A conversation with a Georgetown nursing student about gender ideology quickly escalates into a tense exchange over biology, medicine, and identity. Emotions rise as both sides challenge each other’s ...

Neurocrine Biosciences, Inc. leverages a strong cash position and a neuropsychiatry pipeline to drive long-term commercial growth. See why NBIX stock is a buy.

SK bioscience will continue to strengthen a Mid- to Long-Term global vaccine strategy centered on universal vaccines for future pandemic preparedness INCHEON, South Korea, Jan. 29, 2026 /PRNewswire/ - ...

We came across a bullish thesis on Twist Bioscience Corporation on Clinical Catalysts’s Substack. In this article, we will ...

Waters has announced the completion of its acquisition of BD’s Biosciences and Diagnostic Solutions businesses.

Approximately SEK 91 million (gross) raised in December, strengthening financial position with additional warrant upside in 2026.Mitazalimab validation: OPTIMIZE-1 biomarker results ...

Cytek Biosciences, Inc. ('Cytek Biosciences” or 'Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday, ...

Twist Bioscience (NASDAQ: TWST) released its Q1 earnings on Monday, February 2, 2026 at 07:15 AM. Here's what's important ...